On the stock market since 2020, it operates in the world of health and science. It has 1,827 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 28% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Bets Against the Stock: The number of investors betting on a fall stands out.
An investor who bought at the very peak is down 63% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 3 years, sales grew about 33% a year on average.
The company sells $2.8B a year; the problem isn’t sales — it’s costs running above that number.
A loss of $36.2M against $2.8B in annual sales.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
The weight of investors positioned for a fall can be felt in the market. Council score: 2/10.
On our five-subject report card, SAEYY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: SAEYY has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.